That low grow is really you know what. Nice approved a treatment for rare diseases which cost more than $1.1 mil. He calls DCVax- L treatment which cost around $175k expensive. Watta idiot. He can’t even follow the bashers txt book.
You know fudsters are getting desperate when they have to reach down to the bottom of the barrel to get the craziest of arguments: DCVax-L will be approved as the only viable option for the deadliest of cancers, GBM, yet the company will not make any money. He knows what's coming. LMAOF!!!!
Market Data 
Markets 
AI
